172 related articles for article (PubMed ID: 28189846)
61. Contribution of the HNE-immunohistochemistry to modern pathological concepts of major human diseases.
Zarkovic K; Jakovcevic A; Zarkovic N
Free Radic Biol Med; 2017 Oct; 111():110-126. PubMed ID: 27993730
[TBL] [Abstract][Full Text] [Related]
62. Dose-dependent antioxidant function of resveratrol demonstrated via modulation of reactive oxygen species in normal human skin fibroblasts in vitro.
Jagdeo J; Adams L; Lev-Tov H; Sieminska J; Michl J; Brody N
J Drugs Dermatol; 2010 Dec; 9(12):1523-6. PubMed ID: 21120261
[TBL] [Abstract][Full Text] [Related]
63. Interplay between membrane lipid peroxidation, transglutaminase activity, and cyclooxygenase 2 expression in the tissue adjoining to breast cancer.
Balestrieri ML; Dicitore A; Benevento R; Di Maio M; Santoriello A; Canonico S; Giordano A; Stiuso P
J Cell Physiol; 2012 Apr; 227(4):1577-82. PubMed ID: 21678409
[TBL] [Abstract][Full Text] [Related]
64. [Lipid peroxidation level in gastrointestinal tract tumors].
Czeczot H; Scibior-Bentkowska D; Skrzycki M; Majewska M; Podsiad M
Pol Merkur Lekarski; 2010 Nov; 29(173):309-14. PubMed ID: 21268915
[TBL] [Abstract][Full Text] [Related]
65. ESR evidence for in vivo formation of free radicals in tissue of mice exposed to single-walled carbon nanotubes.
Shvedova AA; Kisin ER; Murray AR; Mouithys-Mickalad A; Stadler K; Mason RP; Kadiiska M
Free Radic Biol Med; 2014 Aug; 73():154-65. PubMed ID: 24863695
[TBL] [Abstract][Full Text] [Related]
66. De novo lipogenesis protects cancer cells from free radicals and chemotherapeutics by promoting membrane lipid saturation.
Rysman E; Brusselmans K; Scheys K; Timmermans L; Derua R; Munck S; Van Veldhoven PP; Waltregny D; Daniëls VW; Machiels J; Vanderhoydonc F; Smans K; Waelkens E; Verhoeven G; Swinnen JV
Cancer Res; 2010 Oct; 70(20):8117-26. PubMed ID: 20876798
[TBL] [Abstract][Full Text] [Related]
67. Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: what is the clinical significance?
Touyz RM
Hypertension; 2004 Sep; 44(3):248-52. PubMed ID: 15262903
[TBL] [Abstract][Full Text] [Related]
68. Oxidative stress marker in oral cancer: A review.
Katakwar P; Metgud R; Naik S; Mittal R
J Cancer Res Ther; 2016; 12(2):438-46. PubMed ID: 27461591
[TBL] [Abstract][Full Text] [Related]
69. Activation of ALDH1A1 in MDA-MB-468 breast cancer cells that over-express CYP2J2 protects against paclitaxel-dependent cell death mediated by reactive oxygen species.
Allison SE; Chen Y; Petrovic N; Zhang J; Bourget K; Mackenzie PI; Murray M
Biochem Pharmacol; 2017 Nov; 143():79-89. PubMed ID: 28756208
[TBL] [Abstract][Full Text] [Related]
70. Chronic inflammation and oxidative stress in human carcinogenesis.
Federico A; Morgillo F; Tuccillo C; Ciardiello F; Loguercio C
Int J Cancer; 2007 Dec; 121(11):2381-6. PubMed ID: 17893868
[TBL] [Abstract][Full Text] [Related]
71. A radical approach to cancer.
Das U
Med Sci Monit; 2002 Apr; 8(4):RA79-92. PubMed ID: 11951081
[TBL] [Abstract][Full Text] [Related]
72. The paradoxical role of lipid peroxidation on carcinogenesis and tumor growth: a commentary.
González MJ; Riordan NH
Med Hypotheses; 1996 Jun; 46(6):503-4. PubMed ID: 8803930
[TBL] [Abstract][Full Text] [Related]
73. Co-Operation between Aneuploidy and Metabolic Changes in Driving Tumorigenesis.
Newman DL; Gregory SL
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31540349
[TBL] [Abstract][Full Text] [Related]
74. Immunoproteasomal Processing of Isolevuglandin Adducts in Hypertension.
de la Visitación N; Chen W; Krishnan J; Van Beusecum JP; Amarnath V; Hennen EM; Zhao S; Saleem M; Ao M; Harrison DG; Patrick DM
bioRxiv; 2023 Apr; ():. PubMed ID: 37383945
[TBL] [Abstract][Full Text] [Related]
75. Inflammation Biomarker Response to Oral 2-Hydroxybenzylamine (2-HOBA) Acetate in Healthy Humans.
Rathmacher JA; Fuller JC; Abumrad NN; Flynn CR
Inflammation; 2023 Aug; 46(4):1343-1352. PubMed ID: 36935449
[TBL] [Abstract][Full Text] [Related]
76. Mass spectrometry detection of isolevuglandin adduction to specific protein residues.
Charvet CD; Pikuleva IA
Methods Mol Biol; 2015; 1208():285-98. PubMed ID: 25323515
[TBL] [Abstract][Full Text] [Related]
77. Mechanisms and effects of lipid peroxidation.
Cheeseman KH
Mol Aspects Med; 1993; 14(3):191-7. PubMed ID: 8264333
[TBL] [Abstract][Full Text] [Related]
78. Isolevuglandins and cardiovascular disease.
Davies SS; May-Zhang LS
Prostaglandins Other Lipid Mediat; 2018 Nov; 139():29-35. PubMed ID: 30296489
[TBL] [Abstract][Full Text] [Related]
79. The generation and actions of isoprostanes.
Roberts LJ; Morrow JD
Biochim Biophys Acta; 1997 Apr; 1345(2):121-35. PubMed ID: 9106492
[No Abstract] [Full Text] [Related]
80. Evidence in support of potential applications of lipid peroxidation products in cancer treatment.
Erejuwa OO; Sulaiman SA; Ab Wahab MS
Oxid Med Cell Longev; 2013; 2013():931251. PubMed ID: 24369491
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
